|
1
|
Sadock BJ, Sadock VA and Ruiz P: Kaplan and Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry. 11th edition. Wolters Kluwer Health, PA, 2015.
|
|
2
|
Marinescu I, Stovicek PO, Marinescu D and Papacocea T: Cinnarizine-potential trigger of the dopamine supersensitivity psychosis in patients with paranoid schizophrenia particular neurobiochemical model. Rev Chim. 70:3003–3007. 2019.
|
|
3
|
Saha S, Chant D, Welham J and McGrath J: A systematic review of the prevalence of schizophrenia. PLoS Med. 2(e141)2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Moreno-Küstner B, Martín C and Pastor L: Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 13(e0195687)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lincă FI, Alexandrescu L, Cucu N and Alexandrescu B: Investigation of FTO gene-BMI association in a Romanian sample: A functional genomic interpretation. Biointerface Res Appl Chem. 13(230)2023.
|
|
6
|
McClellan J and Stock S: American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 52:976–990. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murray RM, Bhavsar V, Tripoli G and Howes O: 30 Years on: How the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis. Schizophr Bull. 43:1190–1196. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, et al: A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev. 65:185–194. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hollis C and Palaniyappan L: Schizophrenia and psychosis. In: Rutter's Child and Adolescent Psychiatry. Thapar A, Pine DS, Leckman JF, Scott S, Snowling MJ and Taylor E (eds). 6th edition. Wiley, pp774-792, 2015.
|
|
10
|
Scherr M, Hamann M, Schwerthöffer D, Froböse T, Vukovich R, Pitschel-Walz G and Bäuml J: Environmental risk factors and their impact on the age of onset of schizophrenia: Comparing familial to non-familial schizophrenia. Nord J Psychiatry. 66:107–114. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Martínez-Ortega JM, Carretero MD, Gutiérrez-Rojas L, Díaz-Atienza F, Jurado D and Gurpegui M: Winter birth excess in schizophrenia and in non-schizophrenic psychosis: Sex and birth-cohort differences. Prog Neuropsychopharmacol Biol Psychiatry. 35:1780–1784. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chandra IS, Kumar KL, Reddy MP and Reddy CMPK: Attitudes toward medication and reasons for non-compliance in patients with schizophrenia. Indian J Psychol Med. 36:294–298. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
McGrath J, Brown A and St Clair D: Prevention and schizophrenia-the role of dietary factors. Schizophr Bull. 37:272–283. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu MQ, Sun WS, Liu BX, Feng GY, Yu L, Yang L, He G, Sham P, Susser E, St Clair D and He L: Prenatal malnutrition and adult schizophrenia: Further evidence from the 1959-1961 Chinese famine. Schizophr Bull. 35:568–576. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Flegr J, Príplatova L, Hampl R, Bicikovíá M, Ripova D and Mohr P: Difference of neuro- and immunomodulatory steroids and selected hormone and lipid concentrations between Toxoplasma-free and Toxoplasma-infected but not CMV-free and CMV-infected schizophrenia patients. Neuro Endocrinol Lett. 35:20–27. 2014.PubMed/NCBI
|
|
16
|
Müller N, Weidinger E, Leitner B and Schwarz MJ: The role of inflammation in schizophrenia. Front Neurosci. 9(372)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dorrington S, Zammit S, Asher L, Evans J, Heron J and Lewis G: Perinatal maternal life events and psychotic experiences in children at twelve years in a birth cohort study. Schizophr Res. 152:158–163. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hosak L: New findings in the genetics of schizophrenia. World J Psychiatry. 3:57–61. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Boydell J: Risk factors for schizophrenia. Expert Rev Neurother. 1:183–191. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Semple DM, McIntosh AM and Lawrie SM: Cannabis as a risk factor for psychosis: Systematic review. J Psychopharmacol. 19:187–194. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hickman M, Vickerman P, Macleod J, Kirkbride J and Jones PB: Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction. 102:597–606. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tandon R, Keshavan MS and Nasrallah HA: Schizophrenia, ‘just the facts’ what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 102:1–18. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Morgan C and Fisher H: Environment and schizophrenia: Environmental factors in schizophrenia: childhood trauma-a critical review. Schizophr Bull. 33:3–10. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Clarke M, Whitty P, Browne S, McTigue O, Kamali M, Gervin M, Kinsella A, Waddington JL, Larkin C and O'Callaghan E: Untreated illness and outcome of psychosis. Br J Psychiatry. 189:235–240. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Beckers T, Maassen N, Koekkoek B, Tiemens B and Hutschemaekers G: Can social support be improved in people with a severe mental illness? A systematic review and meta-analysis. Curr Psychol. 42:14689–14699. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang CX, Ren XH, Yang XM, Fan RX, Wang Y, Li YL, Jiang HJ, Liu YY and Liu X: Quality of life and its influencing factors among schizophrenia patients living in urban and rural areas. Sichuan Da Xue Xue Bao Yi Xue Ban. 54:608–613. 2023.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
27
|
Sher L and Kahn RS: Suicide in schizophrenia: An educational overview. Medicina (Kaunas). 55(361)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mork E, Mehlum L, Barrett EA, Agartz I, Harkavy-Friedman JM, Lorentzen S, Melle I, Andreassen OA and Walby FA: Self-harm in patients with schizophrenia spectrum disorders. Arch Suicide Res. 16:111–123. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chan MKY, Bhatti H, Meader N, Stockton S, Evans J, O'Connor RC, Kapur N and Kendall T: Predicting suicide following self-harm: Systematic review of risk factors and risk scales. Br J Psychiatry. 209:277–283. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Crișan RM, Băcilă CI and Morar S: The role of psychological autopsy in investigating a case of atypical suicide in schizophrenia: A case report with a brief review of literature. Egypt J Forensic Sci. 12(30)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Iliuta FP, Manea MC, Budisteanu M, Andrei E, Linca F, Rad F, Cergan R and Ciobanu AM: Magnetic resonance imaging of brain anomalies in adult and pediatric schizophrenia patients: Experience of a Romanian tertiary hospital. Exp Ther Med. 22(1098)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Iliuta FP, Manea MC, Budisteanu M, Ciobanu AM and Manea M: Magnetic resonance imaging in schizophrenia: Luxury or necessity? (Review). Exp Ther Med. 22(765)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th edition. American Psychiatric Association, Arlington, VA, 2009.
|
|
34
|
American Medical Association: ICD-10-CM 2022: The official codebook with guidelines. American Medical Association, Chicago, 2021.
|
|
35
|
American Psychiatric Association and American Psychiatric Association: Diagnostic and statistical manual of mental disorders: DSM-5. 5th edition. American Psychiatric Association, Washington, DC, 2013.
|
|
36
|
Raven JC: Raven Standard Progressive Matrices, 2016. https://www.pearsonassessments.com/store/usassessments/en/Store/Professional-Assessments/Cognition-%26-Neuro/Raven’s-Progressive-Matrices-Second-Edition-%7C-Raven%27s-2/p/100001960.html. Accessed Mar 22, 2018.
|
|
37
|
Hany M, Rehman B, Azhar Y and Chapman J: Schizophrenia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024.
|
|
38
|
Messias EL, Chen CY and Eaton WW: Epidemiology of schizophrenia: Review of findings and myths. Psychiatr Clin North Am. 30:323–338. 2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Allott KA, Schäfer MR, Thompson A, Nelson B, Bendall S, Bartholomeusz CF, Yuen HP, McGorry PD, Schlögelhofer M, Bechdolf A and Amminger GP: Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants. Schizophr Res. 153:25–31. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Alelú-Paz R and Iturrieta-Zuazo I: Human endogenous retroviruses: Their possible role in the molecular etiology of the schizophrenia. Open J Genet. 2:70–76. 2012.
|
|
41
|
Brown AS and McGrath JJ: The prevention of schizophrenia. Schizophr Bull. 37:257–261. 2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Insiyah I, Rohimah YT, Astuti SLD, Lestari S, Suyanto S and Sulistyowati EC: Predicting quality of life of schizophrenia patients. JKG. 8:22–32. 2023.
|
|
43
|
Ifteni P, Correll CU, Burtea V, Kane JM and Manu P: Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients. Schizophr Res. 155:72–76. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chou IJ, Kuo CF, Huang YS, Grainge MJ, Valdes AM, See LC, Yu KH, Luo SF, Huang LS, Tseng WY, et al: Familial aggregation and heritability of schizophrenia and co-aggregation of psychiatric illnesses in affected families. Schizophr Bull. 43:1070–1078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Nyer M, Kasckow J, Fellows I, Lawrence EC, Golshan S, Solorzano E and Zisook S: The relationship of marital status and clinical characteristics in middle-aged and older patients with schizophrenia and depressive symptoms. Ann Clin Psychiatry. 22:172–179. 2010.PubMed/NCBI
|
|
46
|
Černis E, Vassos E, Brébion G, McKenna PJ, Murray RM, David AS and MacCabe JH: Schizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia? Eur psychiatr. 30:628–632. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Linca FI, Budisteanu M, Popovici DV and Cucu N: The moderating role of emotional regulation on the relationship between school results and personal characteristics of pupils with attention deficit/hyperactivity disorder. Children (Basel). 9(1637)2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cantor-Graae E, Pedersen CB, McNeil TF and Mortensen PB: Migration as a risk factor for schizophrenia: A Danish population-based cohort study. Br J Psychiatry. 182:117–122. 2003.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Selten JP and Cantor-Graae E: Hypothesis: Social defeat is a risk factor for schizophrenia? Br J Psychiatry Suppl. 51:s9–s12. 2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Torrey EF, Buka S, Cannon TD, Goldstein JM, Seidman LJ, Liu T, Hadley T, Rosso IM, Bearden C and Yolken RH: Paternal age as a risk factor for schizophrenia: How important is it? Schizophr Res. 114:1–5. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Van Os J and Jones PB: Neuroticism as a risk factor for schizophrenia. Psychol Med. 31:1129–1134. 2001.PubMed/NCBI View Article : Google Scholar
|
